BlackRock’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,127,197
Closed -$22M 5823
2022
Q4
$22M Sell
1,127,197
-51,646
-4% -$1.04M ﹤0.01% 2981
2022
Q3
$24.6M Buy
1,178,843
+13,279
+1% +$379K ﹤0.01% 2917
2022
Q2
$37.3M Sell
1,165,564
-7,169
-0.6% -$270K ﹤0.01% 2689
2022
Q1
$47.8M Sell
1,172,733
-56,884
-5% -$2.38M ﹤0.01% 2623
2021
Q4
$54.9M Buy
1,229,617
+11,478
+0.9% +$552K ﹤0.01% 2605
2021
Q3
$60.7M Sell
1,218,139
-16,792
-1% -$875K ﹤0.01% 2531
2021
Q2
$66.3M Buy
1,234,931
+15,191
+1% +$763K ﹤0.01% 2512
2021
Q1
$56M Sell
1,219,740
-31,818
-3% -$1.53M ﹤0.01% 2544
2020
Q4
$61.1M Buy
1,251,558
+123,723
+11% +$5.91M ﹤0.01% 2359
2020
Q3
$50M Sell
1,127,835
-957
-0.1% -$40.4K ﹤0.01% 2304
2020
Q2
$43.4M Sell
1,128,792
-62,773
-5% -$2.54M ﹤0.01% 2332
2020
Q1
$49M Buy
+1,191,565
New +$57.1M ﹤0.01% 2061

BlackRock's ELAT Position: Q1 2023 in Review

BlackRock sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q1 2023, closing a stake of 1,127,197 shares — an estimated $22M sold.

BlackRock first reported a position in ELAT in Q1 2020 and held it in 12 quarters. The position peaked at $66.3M in Q2 2021. 0 funds tracked by Wall St. Rank hold ELAT as of Q1 2023.

  • BlackRock reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q1 2023 after selling out during the quarter.
  • BlackRock sold 1,127,197 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q1 2023, an estimated $22M.
  • BlackRock first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q1 2020 and held it in 12 quarters.
  • BlackRock's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $66.3M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q1 2023.

Based on BlackRock's 13F filing for Q1 2023, filed 12 May 2023.